Australia markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.31-0.36 (-1.93%)
At close: 04:00PM EDT
18.31 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
295,390
330,531
108,463
48,661
335,659
Operating expenses
Research development
402,076
423,876
358,732
265,353
212,615
Selling general and administrative
101,450
103,354
90,475
79,059
60,326
Total operating expenses
503,526
527,230
449,207
344,412
272,941
Operating income or loss
-208,136
-196,699
-340,744
-295,751
62,718
Income before tax
-137,215
-145,194
-325,970
-291,156
71,959
Income tax expense
-
30
21
-575
823
Income from continuing operations
-137,245
-145,224
-325,991
-290,581
71,136
Net income
-137,245
-145,224
-325,991
-290,581
71,136
Net income available to common shareholders
-137,245
-145,224
-325,991
-290,581
71,136
Basic EPS
-0.94
-
-2.60
-2.39
0.65
Diluted EPS
-0.94
-
-2.60
-2.39
0.63
Basic average shares
136,047
-
125,531
121,525
108,974
Diluted average shares
136,047
-
125,531
121,525
112,703